SCHEMBL21872091

SCHEMBL21872091

CC(C)c1c(Cl)cc(-c2ccccc2)cc1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR2 Q92731 1/20 0.47
AKR1C2 P52895 1/20 0.44
AKR1C1 Q04828 1/20 0.44
CYP1A2 P05177 2/20 0.42
ALDH1A1 P00352 2/20 0.41
PTGS2 P35354 1/20 0.41
KDM4E B2RXH2 2/20 0.41
HTT P42858 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
POLB P06746 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
CYP2A6 P11509 1/20 0.39
FTO Q9C0B1 1/20 0.39
RHEB Q15382 1/20 0.39
S1PR1 P21453 1/20 0.38
S1PR3 Q99500 1/20 0.38
AHR P35869 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21872207 0.86 ESR2 (0.40) ESR2AKR1C2AKR1C1CYP1A2ALDH1A1
SCHEMBL8674451 0.77 CA1 (0.44) ALDH1A1PTGS2KDM4EHTTSMN1; SMN2
SCHEMBL19078687 0.77 ESR2 (0.52) ESR2CYP1A2PTGS2CYP2C9CYP2C19
SCHEMBL22004194 0.77 CA1 (0.55) ESR2AKR1C2AKR1C1CYP1A2HTT
SCHEMBL22141287 0.76 ESR2 (0.50) ESR2AKR1C2AKR1C1CYP1A2ALDH1A1
SCHEMBL1697200 0.76 ESR2 (0.50) ESR2AKR1C2AKR1C1CYP1A2ALDH1A1
SCHEMBL9747112 0.76 AHR (0.58) ESR2ALDH1A1PTGS2KDM4EHTT
SCHEMBL17878525 0.76 AKR1C2 (0.43) AKR1C2AKR1C1CYP1A2ALDH1A1PTGS2
SCHEMBL40528 0.75 PTGS2 (0.58) CYP1A2ALDH1A1PTGS2MEN1KMT2A
SCHEMBL4458296 0.75 AHR (0.64) ESR2AKR1C2AKR1C1CYP1A2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200115357-A1 LIVER X RECEPTORS (LXR) MODULATORS PHENEX-FXR GMBH (DE) 2020-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200115357-A1 LIVER X RECEPTORS (LXR) MODULATORS NR1H2, NR1H3, NR1H4 ESR2 40/4885AKR1C2 1090/4885AKR1C1 1284/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.